Delivery Order SPE2DB22D1202-SPE2DB25FVHX0
- Not listed
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $6,085.54 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The non-set-aside, firm fixed price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order represents a single pharmaceutical transaction executed under AmerisourceBergen's broader federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,088.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and employs firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $12,077.82 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. The competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract performs in Conshohocken, Pennsylvania, at the vendor's corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,202.67 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on July 24, 2025, with a completion date of July 25, 2025, and represents a non-set-aside competitive procurement. The award was issued from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $3,850.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,847.34 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This firm fixed price delivery order, issued on August 5, 2025, represents a single transaction under a larger contract vehicle. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $6,700.07 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, was competitively awarded with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVHX0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,586.56 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 21, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents one of numerous competitively awarded transactions the company executes through this vehicle to meet the federal government's ongoing pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/20/25 |